Article Details
Retrieved on: 2019-07-08 19:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The company emerged from Boston's <b>Third Rock Ventures</b> in 2015 with $45 million and plans to improve upon an antifungal drug, plus develop others ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here